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Abstract: 
Objective 
The purpose of this study was to explore system and clinician-related barriers, and predictors for 
the adoption of the National Comprehensive Cancer Network Distress Management Guideline 
(DMG) into oncology outpatient practice. 
Methods 
This descriptive, correlational study surveyed a national sample of oncology nurses working in 
an outpatient setting who completed the survey electronically or by mail. 
Results 
Study respondents (n = 409) were predominantly certified nurses (84%) yet largely unfamiliar 
with the DMG; 17% of respondents were using the DMG. Time, staff uncertainties and 
ambiguous accountability were the largest barriers to not assessing distress. Compared with 
those not using any assessment tool, those using the DMG were more comfortable discussing 
distress, worked as an oncology nurse longer, scored colleagues higher on valuing distress 
screening and had more organizational processes in place to support evidence-based practices. 
Significant predictors of DMG use included higher familiarity with the DMG (OR 3.81, 
p < .001), lower perceived barriers (OR 0.41, p = .001), non-profit status (OR 3.93, p = .05) and 
urban or rural (versus suburban) work settings (OR 04.59, p = .04; overall model chi-square 
133.25, df 12, p < .001, Nagelkerke R2 .67). 
Conclusions 
This study identified barriers and predictors to using the DMG, which are amenable to 
interventions. DMG adoption may be augmented by interventions, which increase familiarity 
with the guideline. Additionally, adoption of the DMG may improve through explicit articulation 
of the responsibilities oncology team members have in cancer-related distress screening and 
management. Further studies are needed to evaluate the efficacy of such interventions and their 
impact on patient care outcomes. 
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Article: 
Introduction 
The reported incidence of cancer-related distress is between 5% and 70%, dependent upon the 
cancer site and stage [1-4]. Patient outcomes associated with cancer-related distress include 
increased depression, lower quality of life and reduced adherence to treatment plan [5-10]. The 
assessment and management of cancer-related distress thus has the potential to improve patient 
outcomes throughout the cancer trajectory. 
 
Implementation of evidence-based practice guidelines helps ensure high-quality and cost-
effective oncology care [11]. The National Comprehensive Cancer Network (NCCN) developed 
the Distress Management Guideline [DMG; [12]] to address the psychosocial needs of cancer 
patients. The guideline recommends routine screening of cancer-related distress using the 
Distress Thermometer. Despite research evidence and recommendations for practice included in 
the DMG, distress continues to be under-assessed and under-estimated in people with cancer 
[13]. 
 
Although the implementation of an evidence-based guideline can ensure quality, there are 
inherent difficulties in implementation because of differences between the controlled 
environment in which research is conducted and the real-life complexities of clinical practice 
settings [14]. Despite that the DMG has existed since 1999, investigators [15] found in a 2005 
survey of institutional representatives from 18 NCCN sites that only eight of 15 (53%) 
responding NCCN member institutions routinely screened for distress, three of which used the 
distress thermometer. Only three institutions screened every patient, and the other five screened 
certain groups of cancer patients. Reasons provided for not routinely screening for distress 
included a lack of valuing the assessment and insufficient resources despite all 15 NCCN 
institutions reporting the availability of mental health services in their setting. 
 
Oncology physicians increasingly use evidence-based guidelines for quality performance 
measurement [16, 17]. In a survey of medical oncologists (n = 448) in 2007, over half reported 
routinely assessing for distress. However, only 14% reported screening using a validated 
instrument with the majority asking direct questions or observing the patient. Additionally, only 
33% were at least somewhat familiar with the NCCN DMG [18]. The study reported the largest 
barriers to screening for distress as perceived by physicians were lack of time, limited referral 
resources and unwillingness of patients to discuss distress. Familiarity with the NCCN DMG was 
the strongest predictor of screening. Other significant predictors included clinician gender 
(females more likely to screen), longer time in practice, availability of mental health resources 
and clinician uncertainty about identifying distress. Interestingly, only the barrier of limited 
referral resources coincided with the predictors for routine screening. 
 
Distress management must be an interdisciplinary effort [12]. Interventions are based upon the 
nature of the distress source and may include chaplains, social workers, mental health 
professionals, family or physicians. The screening and decision to refer is completed by the 
oncology team, often by a nurse. Fitch's [19] review described the nursing roles of assessment, 
patient education and symptom management being facilitated by the use of Distress 
Thermometer. Fitch also noted that nurses report higher levels of clinical uptake of distress 
screening results than other clinicians. Loscalzo, Clark and Holland [20] identified nurses as 
‘natural allies’ (p. 20) to patient psychosocial needs and emphasized the nursing role of 
screening and referral to the psychosocial team. The critical role was also expressed by Vitek et 
al. [21] as they describe nurses to have frequent and often prolonged contact with the patient 
providing the opportunity for screening, in-depth assessment and appropriate referral. The 
Canadian experiences [22] of implementing distress assessment as the sixth vital sign emphasize 
the change in values and culture of the clinical setting, often facilitated or championed by 
positions held by nurses. 
 
However, there are no studies of nursing awareness of the NCCN DMG or research to 
characterize factors that influence DMG's adoption by nurses. The purpose of this translational 
study was to explore system and clinician-related barriers, and predictors of adoption of the 
DMG into routine oncology nursing practice in the outpatient setting. The specific study aims 
were the following: (i) assess oncology nurse level of awareness and adoption of the DMG; (ii) 
examine relationships between organizational and clinician characteristics, and adoption 
practices; and (iii) identify factors that predict adoption of the guideline. 
 
Theoretical framework 
The study was guided by Rogers' Theory of the Diffusion of Innovation [23]. The theory posits 
that the rate of adoption of findings into routine practice is affected by how individuals and 
organization perceive the relative advantage, compatibility, complexity, trial-ability and 
observability of an innovation. Rogers also describes how the number of people involved in 
making a decision to adopt an innovation has an effect on the rate of implementation. Other 
variables influencing the rate of diffusion of an innovation into practice include the type of 
communication channels used, the social system in which the innovation is to be implemented 
and the extent of the change agents' promotional efforts. 
 
 
Design/methods 
This descriptive, correlational study surveyed a randomly selected national sample of Oncology 
Nursing Society members. An electronic survey followed a tailored design approach [24]. The 
variables in this study addressed clinician, organizational and guideline issues related to 
implementing evidence into practice [14, 25]. 
 
Study sample/setting 
The study sampling frame consisted of Oncology Nursing Society (ONS) members whose 
membership profile included an e-mail address and whose primary work setting was identified as 
‘outpatient hospital based clinic’, ‘outpatient other’, ‘outpatient physician office/infusion center’, 
‘outpatient radiation free standing’ or ‘outpatient hospital based’. Eligible participants had to be 
practising within the USA. To adequately represent the approximately 37,000 member ONS 
population, a sample size of 380 was indicated by a priori random sample size estimation using a 
95% confidence level and 5% confidence interval. 
 
Instruments 
Participant demographic information was collected to describe the sample. With permission, the 
survey utilized 17 questions from the survey of medical oncologists used by Pirl et al. [18]. Two 
questions assessed nurse awareness and use of the DMG. Additional survey questions were 
developed on the basis of the five variables determining the rate of adoption using Roger's 
Diffusion of Innovation framework. The survey was reviewed by five advanced practice 
oncology nurses familiar with translational science or the DMG. The reviewers evaluated survey 
items for clarity of wording and relevance to Rogers' framework. Questions were retained if they 
were considered relevant by a minimum of 4 (80%) reviewers. Suggestions for improved clarity 
were incorporated. The survey was then completed using a web-based platform by six nurses to 
ensure electronic functionality. The survey required 10–20 min to complete by the six nurses; 
their responses were not used in the analyses. The final survey consisted of 58 questions 
completed by all study participants. Using skip-logic, participants indicating they used the DMG 
were directed to answer an additional 45 questions. 
 
To reduce data complexity, three scales were formed assessing organizational characteristics of 
respondent work place. Eight questions using a six-point scale (1 = not at all, 6 = very much a 
barrier) made up the Barrier scale, assessing the degree to which identified issues were barriers 
to screening for distress in the respondents' practice setting. Similarly, eight items using a six-
point scale comprised the Value scale, indicating the degree to which the nurse perceived his or 
her co-workers value screening for distress. Higher scores indicated higher levels of collegial 
valuing of distress screening. After statistical differences between groups on individual items 
were analyzed, the Barrier and Value scales were analyzed for internal consistency of items 
using Cronbach's coefficient alpha. A four-item Work Culture scale, with higher scores 
indicating a more supportive culture, assessed the degree to which the work place had processes 
in place supporting the use of evidence-based guidelines. Work Culture scale items were 
individually evaluated for adequate cell size and significance between adopters and non-adopters 
using chi-square analysis. Reliability for the scale was determined using the Kuder–Richardson 
20 formula used for dichotomous scale items. 
 
Procedure 
The study received Institutional Review Board approval by the first author's place of 
employment at the time of the study. Consent to participate was implied by completion of the 
survey. A third party contractor managing the membership list for ONS identified eligible 
participants. The principal investigator was blinded to study participants' identity at the time of 
accrual. Systematic randomly selected eligible participants were sent an e-mail explaining the 
study and inviting them to participate. They could respond to the investigator or the contractor if 
they chose to decline participation at that time. A second e-mail was sent with the internet link to 
the electronic survey. Two additional reminder emails were sent 2 weeks apart. 
 
Participants were incentivized to complete the survey by entering a random drawing for one of 
three Apple® iPods. Participants were required to provide an e-mail address for award 
notification. The survey was administered electronically using Survey Monkey®, a secure 
system that allows the participant to complete the survey from any computer having internet 
access [26]. Responses were available only to the study team. 
 
The response rate to the electronic survey was 14%. Because this was less than projected to 
represent the population and after ethical review, a paper survey was sent to the original sample 
members who also had a mailing address listed in the ONS membership data base. The 
demographic responses to the mailed responses were compared with the electronic responses to 
detect possible duplication. 
 
Analysis 
Summary statistics were used to describe the study sample. Responses were analyzed for missing 
data. Items were omitted or a missing response rate reported if there was more than 10% missing 
data points. Depending on the level of measurement, correlations, group comparisons using t-test 
or crosstab analysis with chi-square tests of association were used to examine relationships 
between organizational and clinical characteristics, adoption practices and level of awareness of 
the DMG. Logistical regression was used to determine predictors of DMG adoption. Variables 
with a chi-square or t score significance value of ≤0.2 on separate bivariate analyses were 
entered into the initial regression equation. Alpha was set at .05. Analyses were completed using 
IBM spss (version 19) [27]. 
 
Findings 
Participant flow is illustrated in Figure 1. The total response rate to the survey was 22.8% 
(n = 420). Of the 420, 11 surveys were eliminated because more than 90% of the data were 
missing; the final analyses included 409 surveys. 
 
Figure 1. Study enrollment 
The study sample (refer to Table 1) was predominantly non-Hispanic (98%) and female (99%) 
with only five males responding. Nurses worked an average of 23.15 years (SD 9.80), as an 
oncology nurse for 15.88 years (SD 9.13) and at the current place of employment for 10.59 (SD 
8.77) years. All states were represented in the sample with the exception of Alaska and Vermont. 
There were no statistically significant differences in demographic or study variable responses 
between those completing the survey via postal mail versus those completing the survey 
electronically. 
Table 1. Characteristics of study sample (N = 409) 
Variable n % 
 
Female 384 99 
Ethnicity     
Hispanic, Latin or Spanish origin 9 2 
Non-Hispanic, non-Latina 378 98 
Racial background 388 95 
Asian 7 2 
Black/African American 10 3 
Native Hawaiian/Pacific Islander 1 1 
American Indian/Alaskan Native 3 1 
White 364 94 
Other 3 1 
Education level     
Diploma/associate degree 133 34 
Bachelor degree 159 41 
Masters degree or above 96 23 
Variable n % 
Role     
Staff nurse 179 46 
Management 70 18 
Educator 10 3 
Advanced practice 48 12 
Research 32 8 
Other 50 13 
Work setting     
Area of employment     
Rural 65 16 
Urban 171 42 
Suburban 152 37 
Tax status     
For profit 133 39 
Not-for-profit 205 61 
Not reported 71 17 
Type of care setting     
Hospital based 232 57 
Free standing 128 31 
Other 49 12 
NCCN institution 115 53 
Variable n % 
Did not know 147 36 
Not reported 46 11 
 1. Percentages may not add to 100 because of rounding. 
2. NCCN – National Comprehensive Cancer Network. 
 
There were missing data problems related to characterizing the work setting in terms of 
profit/non-profit, teaching/non-teaching, and public/private with missing data on variables as 
high as 69%. We included profit/non-profit status, although 17.5% were missing as the 
remaining sample size (n = 338) was still adequate for the regression analysis. Data regarding 
affiliation with a college or university and whether the practice was public or private are 
therefore not reported. 
 
Awareness and adoption levels of the Distress Management Guideline 
Few nurses (23%) were ‘highly familiar’ with the DMG, 38% were not at all familiar with the 
DMG and the remaining 39% rated themselves in-between on a six-point scale. Only 69 (17%) 
respondents used the Distress Thermometer and/or other components of the guideline. Fifty 
(13%) respondents indicated they use a different tool to assess for distress, 41 (11%) did not 
know which tool was used and 231 (59%) did not use any systematic tool to assess for distress. 
There was a positive but weak correlation between familiarity with the DMG and comfort levels 
discussing distress (r = .28, R2 = .08, p < .001). Of those using the DMG who responded to the 
question (n = 61), 43 (70%) rated their success of using the DMG as 4 or higher on a six-point 
scale ranging from ‘1 = not at all’ to ‘6 = very successful’. 
 
Organizational and clinician characteristics and adoption practices 
Within the Barrier scale (Cronbach alpha = 0.87), lack of time was rated highest, whereas the 
belief that interventions are ineffective was not much of a barrier (refer to Table 2). Items in the 
Value scale (Cronbach alpha = 0.84) indicated that social workers and advanced practice nurses 
(i.e. clinical nurse specialists and nurse practitioners) were perceived to value distress screening 
the most. Radiation therapists, and managers or administrators were rated the lowest. 
 
Table 2. Average scores of scale items and variables used in regression a 
 
n 
Mean SD 
 
Barriers 396 3.22 1.09 
Lack of time 396 4.1 1.6 
Staff uncertainty about how to identify distress 394 3.4 1.6 
Staff uncertain about treatment options for distress 392 3.4 1.6 
Lack of clarity about who is responsible for screening 395 3.4 1.7 
Limited referral resources 395 3.2 1.7 
Patients unwilling/reluctant to discuss distress 394 3.2 1.2 
Staff uncomfortable discussing distress with patients 394 2.9 1.4 
Belief that interventions are ineffective 393 2.1 1.3 
Perceived valuing of screening by colleagues 397 4.91 .89 
Social workers 313 5.5 1.0 
Advanced practice nurses 307 5.4 0.9 
Psychologist/counselors 234 5.3 1.3 
Staff nurses 390 5.1 1.1 
Chaplains 276 5.1 1.4 
Physicians 391 4.6 1.3 
Radiation therapists 302 4.3 1.5 
Managers/administrators 374 4.3 1.6 
 
n 
Mean SD 
Work Culture scale (range 1–2) 390 1.66 .37 
Patient comfort level discussing distress 408 5.06 .97 
Nurse comfort level discussing distress 407 4.59 .99 
Familiarity with DMG 407 2.85 1.86 
Years as oncology nurse 383 15.88 9.13 
a All but the Culture scale and Years as oncology nurse are based upon a six-point scale from 
‘1 = not at all’ to ‘6 = very much’. 
 
The Work Culture scale (Kuder–Richardson 20 = 0.81) asked whether or not their work setting 
routinely conducted quality improvement activities (79% yes), used a structured process for 
making evidence-based clinical decisions (69% yes), had a routine method for reviewing patient 
outcomes (61% yes) or had an organized process for obtaining feedback about nursing practice 
(54% yes). Thus, over half of the respondents' work places had processes in place, which support 
or promote the use of evidence-based practices. 
 
Distress Management Guideline users versus non-users 
When compared with those not using anything, those using the DMG were more comfortable 
discussing distress (t = −3.58, df 297, p < .001, 95% CI −.72 to .21), were more familiar with the 
guideline (t = −16.59, df 153, p < .001, 95% CI −3.17 to −2.50) and worked as an oncology nurse 
longer (t = −2.14, df 283, p = .03, 95% CI −5.48 to .23). Nurses using the DMG had readily 
available resources when a psychosocial referral was needed. Specifically, those using the DMG 
reported they had a social worker (chi-square = 16.81, p = .001), psychiatrist (chi-square = 11.34, 
p = .01), support group leader (chi-square = 14.74, p = .002), navigator (chi-square = 39.53, 
p < .001) or chaplain (chi-square = 11.0, p = .007) available on the cancer staff or within the 
hospital rather than available in the community or not available at all when compared with non-
users. When comparing those who use the DMG with those who use nothing (Table 3), DMG 
users scored lower on the Barrier scale and higher on the Value and Work Culture scales. 
 
 
Table 3. Comparison of Distress Management Guideline users versus non-users 
Variable n Mean SD t* df CI p* 
 
Barrier scale               
 
Non-users 231 3.45 1.03 5.03 297 .43 to .99 <.01 
 
Users 68 2.73 1.02         
 
Value scale               
 
Non-users 228 4.82 .92 7.97 135 −.56 to −.13 .01 
 
Users 68 5.12 .74         
 
Work Culture scale               
 
Non-users 228 1.58 .39 19.85 153 −.31 to −.14 <.01 
 
Users 69 1.81 .28     
   
 
*  Two-tailed. 
Value and Work Culture scales are reported using equal variance not assumed values. 
Predictors of using the Distress Management Guideline 
Twelve variables met the criteria for being entered into the logistic regression analysis with Use 
versus Non Use as the binary outcome. The model was estimated in two blocks, the first being 
those variables that are considered non-modifiable. The second block consists of variables that 
may be modified. As depicted in Table 4, the likelihood of using the DMG was increased when 
there was higher familiarity with the guideline, lower perceived barriers, when working at a not-
for-profit institution or when working in an urban or rural area. Exploratory analysis using chi-
squared automatic interaction detection software did not identify significant interaction effects 
[28] and thus are not reported. Effect size using Cohen's classification [29], viewed as the 
Nagelkerke pseudo R2, shows a weak effect (.13) for the non-modifiable variables in Block One. 
However, a significant improvement is seen in the model when modifiable variables are added in 
Block Two with the pseudo R2 value increasing to .67 (a medium to large effect). 
 
 
Table 4. Predictors of using the Distress Management Guideline (DMG) 
  Wald p Exp(B) 
Block One – non-modifiable       
Urban, nor rural or suburban 3.39 .07 3.04 
Rural, not urban or suburban 4.12 .04 4.59 
Tax status 3.75 .05 3.93 
Free standing vs. hospital based .002 .96 .97 
Model chi-square 20.93 df 4, p < .001, Nagelkerke R2 = .13 
Block Two – modifiable 
Years as an oncology RN .36 .55 1.02 
Education level of respondent .03 .87 .95 
Familiarity with the DMG 32.59 <.001 3.81 
Patient comfort level with discussing distress 1.07 .30 .69 
RN comfort level with discussing distress .29 .59 .80 
Work culture scale .86 .35 2.25 
Value scale .88 .35 1.40 
Barriers scale 10.74 .001 .41 
Model chi-square 133.25 df 12, p < .001, Nagelkerke R2 = .67 
  
 
Discussion 
Sample 
The response rate to the electronic survey was lower than anticipated. This led to the addition of 
a mailed survey. There was an over-representation of certified nurses (84%) when compared 
with ONS membership certification rate of 52% [30]. The sample had more nurses with greater 
than 10 years of experience in oncology when compared with the ONS membership (67% versus 
47%, respectively) [31]. 
 
Nurse awareness and adoption 
Nurse awareness and adoption of the NCCN DMG was slightly higher in this study than that of 
medical oncologists [18] in 2007 yet remains low. Although the increased familiarity may 
indicate wider dissemination of the guideline, the clinical implications of this finding may be 
influenced by the possibility of more than one respondent working at the same institution. The 
lack of familiarity with the guideline, despite a high percentage of certified nurses in this sample 
as well as ONS member access to multiple articles involving the DMG, calls into question the 
efficacy of evidence dissemination. 
 
Organizational and clinician characteristics relationships with guideline adoption 
Reducing barriers to screening requires work at the individual and organizational levels. Nurses 
routinely conduct patient assessments thus in the ideal position to identify and intervene for 
identified problems. However, interventions to decrease distress may require time or expertise 
beyond what is available to the nurse. Nurses using the DMG rated time as less of a barrier to 
distress screening than those who do not use any tool to screen for distress. This may be due to 
the reduction in clinical care disruptions experienced when distress is routinely assessed and 
managed [20]. The perception of time as a barrier to using the DMG may be influenced by the 
non-user groups' reported lack of available referral resources. The lack of resources for referral 
may shift the responsibility for follow-through with the patient in distress to the nurse, adding to 
the perceived lack of time. The lack of readily available resources for referral was an identified 
barrier, particularly for those not using the DMG. This finding is congruent with other studies 
[22, 32, 33]. As identified in the guideline, collaboration with social workers, mental health 
professionals, spiritual leaders and integrative therapy professionals should occur and would help 
alleviate the barrier of time for nurses by providing adequate follow-up and appropriate referral, 
instrumental in achieving positive patient outcomes for cancer-related distress interventions [22, 
32-34]. It may be necessary to expand the psychosocial intervention skill set of nurses if such 
referral resources are scarce. 
 
Careful documentation of patient distress scores, necessary referral resources and effects on 
patient satisfaction and financial outcomes [20] may help justify funded positions. For outpatient 
cancer care settings with fewer resources available on site, awareness and building excellent 
relationships with community resources may reduce barriers to follow-up. [34]. However, the 
perception that screening may substantially increase the need for referral services is tempered by 
a study conducted in the Netherlands in which up to 60% of patients experiencing psychological 
distress reported they did not need additional support services, preferring to wait or identifying 
concerns related to their distress as currently being managed by self or family [35]. Perhaps 
screening approaches should include a perceived need for additional help or information [36-38]. 
 
Predictors of guideline adoption 
Regression analysis indicated that screening for distress using the DMG may be improved by 
increasing awareness of the guideline and reducing perceived barriers in for-profit and suburban 
outpatient work sites. Increased awareness of the DMG is the first step guideline adoption [23]. 
As discussed earlier, the rate of adoption may be influenced by several characteristics of an 
innovation. Thus, the decision to adopt the DMG may require what Rogers [23] identifies as 
commercialization – marketing the guideline in the practice setting. Internal marketing could 
accelerate the diffusion of the DMG into practice if efforts focus on the advantage of using the 
guideline to meet recent American College of Surgeons accreditation requirements for distress 
screening and management [39]. Engaging key stakeholders such as patient representatives, 
nurses, physicians and mental health professionals in communication and decision-making has 
been a key factor in successful implementation of distress practice guidelines, particularly in 
Canada [22, 33, 40]. 
 
The integration of the process of distress screening and management into the electronic medical 
record with point-of care data capture is recommended. Digitization of the Distress Thermometer 
and programming automatic referrals when desired by the patient [41] or when levels are above 
an indentified cut-off score may have a profound effect on DMG adoption [20, 22, 42]. Having 
the Distress Thermometer integrated into the electronic medical record would also assist a 
clinic's ability to meet the core objectives of Medicare's incentive to demonstrate meaningful use 
of an electronic medical record [43]. 
 
 
Limitations 
The study is limited by the lack of national representation of non-ONS members. Additionally, 
the study may be limited by the low number of men and minority respondents, and over-
representation of certified and oncology experienced nurses. The time needed to complete the 
survey was neither estimated nor measured and may have been too excessive, thereby 
contributing to the lower than anticipated response rate. It is unknown if a non-response bias 
occurred or if more than one nurse from the same institution responded to the survey. 
 
 
Conclusions 
There is substantial room for improvement in the diffusion of the NCCN DMG into practice. 
Focused efforts on increasing nurse awareness of the DMG and reducing perceived barriers will 
be critical to the successful adoption of the DMG. However, awareness is a necessary but 
insufficient approach to practice change. Interventional studies to increase the utilization of the 
DMG and evaluate impact on patient outcomes are needed. 
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